secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-10-08T23:59:59+00:00
Accession:  0000950170-24-113413
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Iterum shareholders approve authority to issue shares without pre-emptive rights at Oct 8 EGM
--------------------------------------------------------------------------------

- Proposal to allow board to allot shares for cash without offering to existing shareholders passed with 9,785,120 votes for, 3,103,525 against, 133,633 abstain.
- Approval required 75% of votes cast; threshold met with ~75.9% in favor.
- Authority provides flexibility for potential future capital raises without pre-emptive obligation.
- Matter considered routine under NYSE rules; no broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024113413/0000950170-24-113413-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024113413/itrm-20241008.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-113413

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer